Continue active refreshing of this index's data?

Continue active refreshing of this index's data?

THEME INDICES

STOXX Global Breakthrough Healthcare

Index Description

The STOXX Global Thematic indices are comprised of companies from selected markets exposed to a defined set of themes: Ageing Population, Automation & Robotics, Digitalisation, Breakthrough Healthcare. These companies operate in business areas that actively participate in social, economic and environmental changes and drive long-term structural trends. To be eligible, companies must derive 50% or more of their revenues from businesses that fall under respective themes. FactSet Revere data is used for a granular breakdown of the revenue sources of the companies in the screening process. This in turn allows enhanced precision in the thematic investment approach and in the selection of companies with substantial exposure to the targeted themes. STOXX Global Thematic indices are also taking ESG considerations into account. Companies that are non-compliant with the Global Standards Screening (GSS), involved in Controversial Weapons activities, or display a Severe (Category 5) Controversy Rating, as identified by Sustainalytics, are excluded. Additional exclusion filters are incorporated, screening companies for involvement in Weapons (Small Arms and Military Contracting), Unconventional Oil & Gas (Arctic Oil and Gas Exploration, Oil Sands and Shale Energy), Conventional Oil & Gas, Thermal Coal, Nuclear Power and Tobacco.

Key facts

  • Index allows targeted investment in Breakthrough Healthcare - a long-term structural trend.
  • Based on FactSet Revere data for a detailed revenue breakdown
  • Inclusion of size and liquidity filters to ensure replicability of the index
  • Leveraging sustainability data from leading provider (Sustainalytics) to avoid exposure to companies engaged in controversial activities

Descriptive Statistics

Index Market Cap (EUR bn) Components (EUR bn) Component weight (%) Turnover (%)
Full Free-float Mean Median Largest Smallest Largest Smallest Last 12 monts
STOXX Global Breakthrough Healthcare N/A 8.8 0.0 0.0 0.2 0.0 2.1 0.0 30.5
STOXX Global Total Market 89,358.5 75,900.1 6.3 0.6 2,842.1 0.0 3.7 0.0 2.7

Supersector weighting (top 10)

Country weighting

Risk and return figures1

Index returns Return (%) Annualized return (%)
Last month YTD 1Y 3Y 5Y Last month YTD 1Y 3Y 5Y
STOXX Global Breakthrough Healthcare 0.7 0.4 -2.2 -17.8 25.5 N/A N/A -2.2 -6.4 4.7
STOXX Global Total Market 2.3 9.5 19.3 23.8 62.7 N/A N/A 19.6 7.4 10.3
Index volatility and risk Annualized volatility (%) Annualized Sharpe ratio2
STOXX Global Breakthrough Healthcare N/A N/A 13.6 19.0 21.7 N/A N/A -0.4 -0.4 0.2
STOXX Global Total Market N/A N/A 9.2 13.0 16.7 N/A N/A 1.5 0.4 0.5
Index to benchmark Correlation Tracking error (%)
STOXX Global Breakthrough Healthcare 0.6 0.7 0.7 0.8 0.8 8.4 9.1 9.6 12.3 13.0
Index to benchmark Beta Annualized information ratio
STOXX Global Breakthrough Healthcare 1.0 1.1 1.1 1.1 1.0 -2.1 -2.3 -2.1 -1.1 -0.4

1For information on data calculation, please refer to STOXX calculation reference guide

2Based on EURIBOR1M

(EUR, Price), all data as of May 31, 2024

THEME INDICES

STOXX Global Breakthrough Healthcare

Fundamentals

Index Price/earnings incl. negative Price/earnings excl. negative Price/book Dividend yield (%)3 Price/sales Price/cash flow
Trailing Projected Trailing Projected Trailing Trailing Trailing
STOXX Global Breakthrough Healthcare -105.7 71.0 34.3 34.3 3.8 0.5 4.3 41.0
STOXX Global Total Market -0.7 18.4 20.0 20.0 2.8 1.9 1.7 5.5

Performance and annual returns

Methodology

The parent index of the STOXX Global Breakthrough Healthcare Index is the STOXX Global Total Market Index. Companies, classified as belonging to a defined set of developed and emerging countries, that derive more than 50% of their most recent total annual revenue from sectors linked to the breakthrough healthcare trend are highlighted as potential index components. The index excludes companies that are not compliant with the Sustainalytics Global Standards Screening assessment or are involved in Controversial Weapons and other controversial activities. Moreover, companies that display high ESG Controversy Ratings are also excluded.

The index applies liquidity and size screens and aims to have a minimum number of 80 components. It is adjusted equal-weighted and reviewed annually in June.

The detailed methodology including the calculation formula can be found in our rulebooks: www.stoxx.com/rulebooks

Versions and symbols

Index ISIN Symbol Bloomberg Reuters
Price EUR CH0325904420 IXBRHLTE .IXBRHLTE
Gross Return EUR CH0325904404 IXBRHLTG .IXBRHLTG
Net Return EUR CH0325904412 IXBRHLTT .IXBRHLTT
Net Return USD CH0325904446 IXBRHLTU IXBRHLTU INDEX .IXBRHLTU
Price USD CH0325904453 IXBRHLTK IXBRHLTK INDEX .IXBRHLTK
Gross Return USD CH0325904438 IXBRHLTS IXBRHLTS INDEX .IXBRHLTS
Net Return GBP CH1213360238 IXBRHLTN IXBRHLTN INDEX .IXBRHLTN
Price GBP CH1213360253 IXBRHLTP .IXBRHLTP
Gross Return GBP CH1213360246 IXBRHLTR .IXBRHLTR

Quick Facts

Weighting Adjusted Equal-weighted
Cap Factor None
No. of components Min. 80
Review frequency Anuual in June
Calculation/distribution Realtime 15 sec
Calculation hours 00:00:00 22:00:00
Base value/base date 1000 on Jun. 20, 2011
History Daily index value since Jun. 20, 2011
Inception date Jun. 21, 2016
To learn more about the inception date, the currency, the calculation hours and historical values, please see our data vendor code sheet.

THEME INDICES

STOXX Global Breakthrough Healthcare

Top 10 Components4

Company Supersector Country Weight
UCB Health Care Belgium 2.106%
Boston Scientific Corp. Health Care USA 2.059%
NATERA Health Care USA 2.036%
NEUROCRINE BIOSCIENCES Health Care USA 2.003%
Amgen Inc. Health Care USA 1.927%
GSK Health Care UK 1.815%
Intuitive Surgical Inc. Health Care USA 1.800%
MEDPACE HOLDINGS Health Care USA 1.726%
CATALENT Health Care USA 1.696%
ABBVIE Health Care USA 1.630%

3Net dividend yield is calculated as net return index return minus price index return

4Based on the composition as of May 31, 2024